NR is also an NAD+ precursor, with more human pharmacokinetic data than NMN. Raises NAD+ comparably to NMN in studies. Whether one is superior is still debated.
Dose: 250-500mg daily.
Caveats: Same caveat as NMN. Long-term human longevity data is not yet established.